We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Lunglife Ai Inc | LSE:LLAI | London | Ordinary Share | ORD USD0.0001 (DI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 9.50 | 9.00 | 10.00 | 9.50 | 9.50 | 9.50 | 0.00 | 07:34:48 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
Date | Subject | Author | Discuss |
---|---|---|---|
19/11/2024 11:01 | That was an encouraging update today . I added a few . | ohisay | |
23/8/2024 01:58 | Investor Meet .. Lets see if they can capitalise on this development in the next six months , MolDX, which oversees the evaluation of molecular diagnostics for Medicare, was considering additional evidence that could broaden the scope of coverage, presenting further opportunities for LungLife. With the LCD in place, LungLife said it had successfully secured the three key components necessary for the commercial launch of LungLB - a billing code, a set price, and now Medicare coverage. That, it said, paved the way for wider adoption of the test by healthcare providers, facilitating earlier and more accurate lung cancer diagnoses for patients with indeterminate lung nodules. “Having a local coverage determination (LCD) for risk stratification testing of indeterminate lung nodules represents a key opportunity for our company,” said chief executive officer Paul Pagano. “It enables us to progress to the next stage of commercialisation by providing a clear pathway to make our innovative LungLB test more accessible and reimbursable under Medicare. “This supports our commitment to enabling 80% of lung cancer to be detected early.” | ohisay | |
19/8/2024 10:18 | my buy and many more are showing as sells. I think things will get better for the company as it should make decent revenues at over $2000 for each lung test. | joseph moran | |
17/8/2024 07:05 | Yes this is getting more interesting by the day. Maybe this is one small pharma company that will make it into sales and profits, before being taken away by the big boys !!! one way or another. | parsons4 | |
06/4/2024 01:39 | Investor Meet recording . Quite an impressive Road map for commercialisation in the next 12 months ..worth keeping an eye on . | ohisay | |
25/3/2024 11:24 | Hopefully buyers returning | joseph moran | |
12/3/2024 12:25 | Buy showing 28.40 time 13.45 Wonder if it means yesterday as it is 12.24 currently.Hopefully buyers returning after days of falls | joseph moran | |
11/3/2024 13:25 | The spread is really small at the moment. The system will not let me sell, the traders have to execute the order. However I can buy for £0.289 the quoted sell price is £0.284 Never known such a small spread on this stock. | joseph moran | |
07/3/2024 16:36 | PI's look like they are out of the loop .Unless that changes the share price is fathomless. | ohisay | |
07/3/2024 15:53 | Shares heading South as well, not great signs....happy to stay on side lines until material progress that will benefit shareholders | qs99 | |
07/3/2024 14:50 | They are asking in their resolutions the authority to issue 100m shares as they deem fit . Current shares in issue is 25m rising to 30m after this placing. Why such a large increase ? The resolutions to be proposed at the Special Meeting are: (a) Resolution 1: To increase the number of Common Shares that the Company is authorised to issue to 100,000,000 Shares in order to accommodate the Placing and Subscription and to provide appropriate headroom to allow for the issue of Common Shares following the Placing and Subscription, and also to generally authorise the Company to allot and issue Common Shares pursuant to the Placing and Subscription. That's a bit of a Red Flag for me . As is the super low buying from the Directors in the placing . As Ive really no idea wtf is going on I'm out FWIW. | ohisay | |
05/3/2024 12:51 | Doh, sorry mate, literally went through this mornings RNS only, village I know, will take a look. Cheers | qs99 | |
05/3/2024 09:20 | Very little info ?? 2. Background to, and reasons for, the Fundraising There's plenty of information there in last nights RNS . | ohisay | |
05/3/2024 08:30 | Indeed...market was flagging something was up IMO! Wonder how far this will take them as v. little info | qs99 | |
04/3/2024 19:12 | Well that could have been worse 15.7% discount on a £1.8m raise funded to April 2025. When hopefully the market has recovered somewhat | hatfullofsky | |
26/1/2024 08:33 | Thnks ohisay Chart looking sickly, I'll wait and see, but as you say, I lilke the tech & market opp....DYOR | qs99 | |
24/1/2024 09:01 | Bit of a decline this am....am waiting for a good entry point... | qs99 | |
18/1/2024 17:30 | Will this need a new fund raising soon do you think? | qs99 | |
17/1/2024 16:07 | Sorry wrong thread was meant for OBD | hatfullofsky |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions